All about 2024 Saxenda lawsuit

Are you eligible for the 2024 Saxenda lawsuit?: Liraglutide has been approved since 2010 for use in the treatment of diabetes under the brand name Victoza. Victoza has already been tagged as a potential cause of pancreatic cancer. According to reports published by the FDA, Victoza was a suspected cause of more than 300 deaths and over 3,000 hospital visits between 2010 and 2014. Around one-third of those fatalities were the result of pancreatic cancer. Hundreds of Victoza lawsuits have already been filed. It makes sense Victoza would go first because it is an older drug. But, if you believe the science that plaintiffs’ lawyers tried to adopt, Saxenda could cause a greater cancer risk because it contains a much higher dose of Liraglutide than Victoza. This drove interest in Saxenda cancer lawsuits. But conclusive scientific proof did not follow. Discover even more details on Saxenda lawsuit.

Saxenda (liraglutide) is a brand-name prescription drug approved by the U.S. Food & Drug Administration (FDA) for weight loss and long-term weight management. It belongs to a class of medications known as glucagon-like peptide 1 (GLP-1) receptor agonists, which work by mimicking gut peptides and helping to regulate blood sugar levels. While Saxenda has been touted as a promising solution for individuals struggling with obesity, the drug has also been associated with a range of concerning Saxenda side effects.

In addition, Dr. Andrew Boxer, a gastroenterologist at Gastroenterology Associates of New Jersey, is among a number of gastroenterologists who said he is seeing an increased number of patients coming into his practice complaining of side effects from these types of drugs. In an article in Healthline, Dr. Boxer continued stating that “I was seeing a tremendous amount of people coming in just with nausea, vomiting, and feelings of fullness, early satiety, just not feeling well … Universally these patients were on GLP-1’s.” (emphasis added). Moreover, doctors have stated additional similar cases are coming to light as the popularity of these drugs has soared.

A resident of Kentucky has initiated a lawsuit against Novo Nordisk A/S and its subsidiaries, accusing the company of failing to warn about the potential risk of permanent stomach paralysis caused by its weight loss medication, Saxenda (liraglutide). The plaintiff consumed Saxenda from March 2019 to April 2021 and is now experiencing gastroparesis, which has resulted in severe consequences such as persistent vomiting and abdominal pain, requiring multiple visits to the hospital. The lawsuit alleges that since the drug’s approval by the FDA in 2014, Novo Nordisk has promoted Saxenda as a weight loss solution without adequately disclosing the potential for gastrointestinal disorders, despite clinical trials indicating such risks.

Additionally, there may be other factors at play that contribute to the development of gastroparesis in individuals who have taken Saxenda such as diabetes mellitus, Parkinson’s disease, following surgery, or with some medications. Notwithstanding, it cannot be seriously debated that there has been a steady increase in the number of individuals who took Saxenda or drugs in the same class and developed gastroparesis. Jaclyn Bjorklund had been prescribed Ozempic for the management of type 2 diabetes for more than a year before she was switched to Mounjaro. Bjorklund claims that her use of both Ozempic and Mounjaro resulted in severe gastrointestinal events, including “severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, [and] teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting and throwing up whole food hours after eating.”

These Saxenda side effects can range from mild impairment of kidney function to severe kidney damage. It is important for patients taking Saxenda to be aware of the potential risk and to closely monitor their kidney function through regular blood tests with their physician. Saxenda and Gallbladder Disease – One of the more concerning side effects of Saxenda is its potential connection to gallbladder disease. The gallbladder is a small organ located beneath the liver, responsible for storing bile, a substance that aids in the digestion of fats. Studies have shown that Saxenda can increase the risk of gallbladder-related problems, such as gallstones and inflammation. Gallstones are solid deposits that form in the gallbladder, often causing pain and discomfort. In severe cases, gallstones can lead to more serious conditions, such as cholecystitis or pancreatitis.

Moreover, healthcare professionals have reported an increase in the number of patients presenting with severe gastrointestinal issues, such as persistent vomiting, after starting Saxenda or similar GLP-1 agonist medications. These reports have raised significant concerns about the potential for Saxenda to contribute to the development of gastroparesis and other debilitating Saxenda side effects. Intestinal blockages have been reported by certain individuals who have taken Saxenda (liraglutide). These blockages can hinder the movement of food and waste through the intestines, leading to intense discomfort, swelling, and vomiting. It appears that this one of the Saxenda side effects is more prevalent in males and in those who have been using the medication for a shorter duration. In 2017, eight cases were documented, with the majority of them requiring surgical intervention. Nevertheless, the specific process by which Saxenda induces these blockages is still not fully understood.

While the evidence is still inconclusive, some studies have suggested a potential link between the use of Saxenda and an increased risk of thyroid cancer. Furthermore, in rare cases, individuals taking Saxenda may experience severe allergic reactions, which can be life-threatening if not treated promptly.

If you took Saxenda and developed gallbladder disease, Saxenda stomach paralysis, or any other serious Saxenda side effects, contact Timothy L. Miles, a Sazenda lawyer in Nashville, today. ?You may be eligible for a Saxenda Lawsuit ?and possibly may be entitled to substantial compensation. Find additional info on

?Timothy L. Miles is a plaintiff’s lawyer in Nashville, Tennessee, and a nationally known top-rated class action and product liability lawyer who has been leading the fight to protect the rights of injured victims for over 20 years.

Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for injured victims, consumers, and shareholders, shaped precedent-setting decisions, and delivered real reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards.